DARCIE LYNN: Open Payments
NPI 1215506407 · BROOKSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,693 in 78 payments from 16 companies in 2025. Trend: 2023 $1,558 · 2024 $835 · 2025 $1,693
Food & beverage: $1,693
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 19 | $401 |
| E.R. Squibb & Sons, L.L.C. | 7 | $159 |
| Otsuka America Pharmaceutical, Inc. | 7 | $149 |
| Vanda Pharmaceuticals Inc. | 5 | $141 |
| Alkermes, Inc. | 5 | $128 |
| Lundbeck LLC | 5 | $106 |
| ABBVIE INC. | 5 | $99 |
| Janssen Pharmaceuticals, Inc | 4 | $88 |
| Collegium Pharmaceutical, Inc. | 4 | $85 |
| Axsome Therapeutics, Inc. | 4 | $78 |
Products named: INGREZZA, REXULTI, COBENFY, FANAPT, ARISTADA, VRAYLAR, Jornay PM, Auvelity.
Industry payments across FL — which companies pay providers there.
